Icon Wealth Advisors LLC Has $3.71 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Icon Wealth Advisors LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 318.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 7,542 shares of the medical equipment provider’s stock after purchasing an additional 5,740 shares during the quarter. Icon Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $3,705,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of ISRG. Creekmur Asset Management LLC lifted its position in Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $26,000. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares in the last quarter. LRI Investments LLC bought a new position in shares of Intuitive Surgical during the first quarter worth about $30,000. Finally, LGT Financial Advisors LLC raised its position in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 54 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on ISRG shares. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada lifted their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Mizuho increased their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $524.61.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 396 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $486.88, for a total value of $192,804.48. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,680,761.28. The trade was a 6.71 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,935 shares of company stock valued at $26,305,169. 0.90% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $550.43 on Friday. Intuitive Surgical, Inc. has a 1 year low of $304.50 and a 1 year high of $551.78. The company has a market capitalization of $196.05 billion, a price-to-earnings ratio of 88.49, a P/E/G ratio of 5.30 and a beta of 1.39. The business has a fifty day simple moving average of $503.57 and a two-hundred day simple moving average of $461.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.